VCNX - Vaccinex, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
511
724
90
316
Cost of Revenue
738
1,033
160
115
Gross Profit
-227
-309
-70
201
Operating Expenses
Research Development
27,103
22,353
16,551
16,028
Selling General and Administrative
5,683
4,619
4,483
4,432
Total Operating Expenses
32,786
26,972
21,034
20,460
Operating Income or Loss
-33,013
-27,281
-21,104
-20,259
Interest Expense
44
392
1,358
2,990
Total Other Income/Expenses Net
114
-1,845
3,703
9,306
Income Before Tax
-32,943
-29,518
-18,759
-13,943
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-32,943
-29,518
-18,759
-13,943
Net Income
-32,943
-29,518
-18,722
-13,943
Net Income available to common shareholders
-31,351
-29,518
-13,621
-26,233
Reported EPS
Basic
-
-5.65
-1.72
-3.30
Diluted
-
-5.65
-1.72
-3.30
Weighted average shares outstanding
Basic
-
5,224
7,940
7,940
Diluted
-
5,224
7,940
7,940
EBITDA
-
-28,903
-17,195
-10,775